Trial intelligence / Profile preview

Physiologic Testosterone Replacement in Premenopausal HIV-Positive Women

NCT00004400Phase 2Completed

Sponsor
Charles Drew University of Medicine & Science
Start
Apr 1997
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of testosterone in HIV-associated wasting syndrome (HIVAW), sponsored by Charles Drew University of Medicine & Science. Started Apr 1997; status: completed.

02

Drugs

testosterone
03

Conditions

HIV-associated wasting syndrome (HIVAW)

Beyond the preview

Go deeper on NCT00004400.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004400.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call